Overactive Bladder Epidemiology Forecast 2025-2034

In the United States, around 33 million of the adult population comprising 40% of women and 30% of men are affected by overactive bladder. The condition is common among people aged 65 years and above, with studies suggesting that women develop overactive bladder at a younger age, typically around 45.

Overactive Bladder Epidemiology Forecast Report Coverage

The “Overactive Bladder Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of overactive bladder. It projects the future incidence and prevalence rates of overactive bladder across various populations. The study covers age, gender, and type as major determinants of the overactive bladder-affected population. The report highlights patterns in the prevalence of overactive bladder over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of overactive bladder in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Overactive Bladder Disease Overview

Overactive bladder (OAB) causes a sudden and strong urge to urinate that may be hard to control, occurring even when the bladder isn't full. Common symptoms include frequent urination during the day or night (nocturia), and, in some cases, involuntary loss of urine. This condition can significantly impact a person’s quality of life, causing embarrassment and emotional distress. Factors such as age, obesity, neurological conditions, and certain medications can increase an individual's risk of developing an overactive bladder.

Overactive Bladder: Treatment Overview

Treatment for overactive bladder involves a combination of lifestyle changes, behavioral therapies, and medications. In severe conditions, surgical interventions may also be needed. Behavioral therapies include pelvic floor exercises (Kegel exercises) for strengthening the pelvic muscles to help control urinary urgency and frequency. Medications like oxybutynin, tolterodine, or solifenacin are used to relax the bladder muscle and reduce contractions. In postmenopausal women, topical estrogen therapy may also be prescribed to manage symptoms.

Epidemiology

The overactive bladder epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for overactive bladder by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for overactive bladder and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• As per a research article published in Scientific Reports (2025), the estimated prevalence of overactive bladder ranges from 12% to 17% in the adult population, with the number of cases slightly higher among women than men.
• Studies show that the prevalence of overactive bladder is the highest among people aged 65 and older, with women often developing the condition at a younger age (typically around 45 years).
• It is estimated that 20% of the population belonging to the age category of 70 years or older experience symptoms of overactive bladder. On the other hand, nearly 30% of individuals aged 75 years or above report symptoms.
• In the United Kingdom, approximately 12-14% of the population is affected by overactive bladder.

Country-wise Overactive Bladder Epidemiology

The overactive bladder epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of overactive bladder varies between countries owing to differences in the prevalence of risk factors (such as obesity, diabetes, and neurological conditions), healthcare access, dietary habits, age distribution, and attitudes towards seeking medical care, among others. In the United States, it is estimated that 33 million adults have overactive bladder, including 40% of women and 30% of men.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of overactive bladder based on several factors.
• Overactive Bladder Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of overactive bladder are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of overactive bladder epidemiology in the 8 major markets?
• What will be the total number of patients with overactive bladder across the 8 major markets during the forecast period?
• What was the country-wise prevalence of overactive bladder in the 8 major markets in the historical period?
• Which country will have the highest number of overactive bladder patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of overactive bladder during the forecast period of 2025-2034?
• What are the currently available treatments for overactive bladder?
• What are the disease risks, signs, symptoms, and unmet needs of overactive bladder?

This product will be delivered within 3-5 business days.